 |
|
|
| |
Pharmacokinetics (PK) of Doravirine and Exposure-Response Analysis:
Efficacy and Safety Implications
|
| |
| |
Reported by Jules Levin
ICAAC Sept 5-9 2014 Wash DC
KL Yee, M Chatterjee, M Dockendorf,
M Lai, H Teppler, & M Rizk
Merck & Co., Inc. Whitehouse Station, NJ, USA
JO Morales-Ramirez
Clinical Research Puerto Rico, San Juan, PR
JM Gatell
Hospital Clinic/IDIBAPS University of Barcelona, Spain
DP Hagins
Chatham County Health Dept, Savannah, GA, USA
M Thompson
AIDS Research Consortium of Atlanta, GA, USA
K Arasteh
EPIMED/Vivantes Auguste-Viktoria-Klinikum,
Berlin, Germany
C Hoffmann
ICH Study Center, Hamburg, German
|
| |
|
|
|
|
|
